ADC Therapeutics SA (ADCT) Insider Trading Disclosures
ADC Therapeutics SA (ADCT) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ADCT
CIK: 1771910
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers AG
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerAlex Fuhrer
Audit LocationLausanne, Switzerland
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-13 | 2026-10-07 | FORM 8-K | 0000950103-26-015465 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097255 | View SEC Doc Filr Page |
| S-8 | 2026-08-13 | — | FORM S-8 | 0000950103-26-012337 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001628280-26-056711 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | FORM 8-K | 0000950103-26-012287 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002147 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001628280-26-047036 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001628280-26-047034 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001628280-26-047033 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001628280-26-047031 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | FORM 8-K | 0000950103-26-010195 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-24 | FORM 8-K | 0000950103-26-009416 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040493 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040492 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040491 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040490 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040489 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040488 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040487 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | FORM 8-K | 0000950103-26-008465 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-01 | FORM 8-K | 0000950103-26-008321 | View SEC Doc Filr Page |
| 10-Q | 2026-05-04 | 2026-03-31 | 10-Q | 0001628280-26-029819 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | 8-K | 0001628280-26-029524 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-24 | — | SCHEDULE 13G/A Filing | 0001104659-26-048804 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-20 | — | FORM DEFA14A | 0000950103-26-005918 | View SEC Doc Filr Page |